Restructuring Complete, Growth Reaccelerates: Q2 Revenue Up 13%, Net Income Attributable to SBC Medical Up 335%, Adjusted EBITDA1 Up 32% Year-over-Year. AI-Enabled Service Enhancements Drive Successful Fee Increases, Positioning the Business for Accelerated Network ExpansionSBC Medical Group Holdings Reports Second Quarter 2026 Financial Results
| ABX | ||
| 2,926.886 | ||
| 88.8410 | 0.0313% | |
| BISNIS-27 | ||
| 435.230 | ||
| 2.7870 | 0.0064% | |
| DBX | ||
| 3,108.698 | ||
| 5.7510 | 0.0019% | |
| ECONOMIC30 | ||
| 88.601 | ||
| 0.4690 | 0.0053% | |
| ESGQKEHATI | ||
| 105.102 | ||
| 0.5620 | 0.0054% | |
| ESGSKEHATI | ||
| 106.192 | ||
| 0.5010 | 0.0047% | |
| I-GRADE | ||
| 159.104 | ||
| 0.4780 | 0.0030% | |
| AUDRP | ||
| 12,667.470 | ||
| 4.5900 | 0.0362% | |
| EURRP | ||
| 20,642.210 | ||
| 4.2600 | 0.0206% | |
| JPYRP | ||
| 111.668 | ||
| -0.1223 | -0.1094% | |
| SINRP | ||
| 13,956.340 | ||
| 12.0400 | 0.0863% | |
| USDRP | ||
| 17,839.000 | ||
| 14.0000 | 0.0785% | |
